e-learning
resources
Virtual 2021
06.09.2021
Innovations in nurse-led interventions in respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study
H. Christensen (Odense, Denmark), S. Svane (Odense, Denmark), H. Madsen (Odense, Denmark)
Source:
Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Session:
Innovations in nurse-led interventions in respiratory diseases
Session type:
E-poster
Number:
1800
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Christensen (Odense, Denmark), S. Svane (Odense, Denmark), H. Madsen (Odense, Denmark). Is an informative application a suitable tool for patients in a diagnostic lung cancer program?A qualitative study. 1800
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines
Source: Annual Congress 2010 - State of the art imaging
Year: 2010
Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer
Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment
Year: 2018
A study of design an original questionnaire for evaluating risks of lung cancer
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
A basic prediction model with clinical parameters to diagnose lung cancer.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
A novel proteomic technique to identify new diagnostic biomarkers for malignant pleural mesothelioma: a feasibility study.
Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease
Year: 2021
The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
A usefulness of 25G core needles for immunohistochemistry and molecular testing in lung cancer patients – a feasibility study
Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration
Year: 2019
A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Evolution in the diagnostic approach to lung cancer
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Individualised field testing is a useful tool to evaluate difficult asthma.
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013
Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire
Source: International Congress 2017 – New insights in chronic respiratory failure
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept